Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Current Neuropharmacology|January 17, 2022
From a Cycle to a Period: The Potential Role of BDNF as Plasticity and Phase-Specific Biomarker in Cocaine Use DisorderAndrea Miuli, Giacomo d'Andrea, Mauro Pettorruso, et al.
Expert Opinion on Pharmacotherapy|January 23, 2023
The pharmacological management of gambling disorder: if, when, and howMauro Pettorruso, Francesco Di Carlo, Vincenzo Maria Romeo, et al.
Calcified Tissue International|June 25, 2011
Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fractureBarbara Mognetti, Silvia Marino, Alessandro Barberis, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 25, 2022
Repetitive transcranial magnetic stimulation in treatment-seeking subjects with cocaine use disorder: A randomized, double-blind, sham-controlled trialGiovanni Martinotti, Mauro Pettorruso, Chiara Montemitro, et al.
International Journal of Oncology|February 11, 2005
Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administrationFranco Ghezzo, Luigi Cesano, Barbara Mognetti, et al.
Journal of Personality Disorders|October 1, 2022
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic ReviewStefania Chiappini, Elena Picutti, Maria Chiara Alessi, et al.
Drug and Alcohol Dependence|June 20, 2016
Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disordersFrancesco Bartoli, Cristina Crocamo, Enrico Biagi, et al.
Current Neuropharmacology|October 25, 2024
Oral and Long-acting Injectable Aripiprazole in Severe Mental Illness and Substance Use Disorder Comorbidity: An Updated Systematic ReviewMario Santorelli, Andrea Miuli, Mauro Pettorruso, et al.
Journal of Chromatographic Science|November 15, 2011
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patientsElisa Pirro, Silvia De Francia, Francesca De Martino, et al.
Pageof 7